Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

Glaxo Wellcome presents development candidate GW-311616A

Aug. 27, 1998

P&G claims alpha2-adrenoceptor agonists with a wide range of potential applications

Aug. 27, 1998

Novel antiinflammatory/antiallergy agents in the pipeline at Japan Energy

Aug. 27, 1998

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Aug. 25, 1998

Pfizer selects LTB4 antagonist for clinical testing

Aug. 25, 1998

Japanese lab describes new agents for asthma and inflammation

Aug. 25, 1998

Sankyo describes NK1/NK2 antagonists for treating asthma

Aug. 25, 1998

First European filing for TOBI

Aug. 24, 1998

Tanabe Seiyaku team identifies new candidates for asthma

Aug. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026